LH inks new agreement to acquire BioReference Health's oncology and related clinical testing services businesses.

This was the stock's sixth consecutive day of losses.

Labcorp will acquire the oncology diagnostics operations from BioReference Health as part of a push to expand in high-growth ...

Labcorp (LH) and OPKO Health (OPK) announced earlier on Tuesday that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO ...

The independent laboratory company has entered an agreement to acquire BioReference Health's oncology diagnostic services.

The sale comes after the Miami company agreed to pay $704,349 to settle allegations that it billed the federal government for ...

Labcorp Holdings has signed a deal to buy certain assets of OPKO Health's BioReference Health unit for up to $225 million. Labcorp on Tuesday said it will pay $192.5 million at closing for ...

Labcorp Holdings Inc. LH, or Labcorp, is prioritizing key specialty testing areas, such as oncology, women’s health, autoimmune disease and neurology, aiming to tap into strong growth opportunities.

Labcorp Holdings Inc. LH, or Labcorp, is positioning itself for sustained growth with a series of strategic acquisitions and partnerships. With a growing emphasis on cell and gene therapy ...

In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on Labcorp Holdings (LH – Research Report), with a ...

Labcorp (LH) and OPKO Health (OPK) announced that they have entered into an agreement for Labcorp to acquire select assets of BioReference ...